More on PTCT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $68.00 |
|
|||
| Open | $68.00 | ||||
| 52 Wk High | $35.40 | ||||
| 52 Wk Low | $4.03 | ||||
| Day High | $68.00 | ||||
| Day Low | $68.00 | ||||
| P/E | 7.23 | ||||
| EPS | $9.40 | ||||
| Volume | 124 | ||||
- Leerink Assumes PTC Therapeutics (PTCT) at Outperform
- Form 4 PTC THERAPEUTICS, INC. For: Sep 09 Filed by: SCHMERTZLER MICHAEL
- Form 4 PTC THERAPEUTICS, INC. For: Aug 26 Filed by: SCHMERTZLER MICHAEL
- Form 8-K PTC THERAPEUTICS, INC. For: Aug 25
- PTC Therapeutics to Participate in Upcoming Investor Conferences
- Form 144/A PTC THERAPEUTICS, INC. Filed by: SCHMERTZLER MICHAEL
- PTC Therapeutics to present Sephience PKU data at SSIEM 2026
- PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety P
- Form 4 PTC THERAPEUTICS, INC. For: Aug 19 Filed by: SCHMERTZLER MICHAEL
- Form 4 PTC THERAPEUTICS, INC. For: Aug 17 Filed by: Boulding Mark Elliott
Entities mentioned with PTCT
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Show More...
